Skip to main content
. 2016 May 31;12(1):680–686. doi: 10.3892/ol.2016.4648

Table V.

Comparison of two confusion matrixes between using BMI only and a combination of BMI and the standard deviation of the computed tomography number of subcutaneous fat area (f5) in classifying patients who received maintenance bevacizumab into ‘long’ and ‘short’ PFS classes.

BMI BMI and f5


PFS class Long Short Long Short
Long 9 7 12 4
Short 7 9 4 12

PFS, progression-free survival; BMI, body mass index.